On August 28, 2018 Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary focus on myelodysplastic syndromes (MDS), reported that the Company will be presenting at the Rodman & Renshaw 20th Annual Global Investment ConferenceSeptember 4-6, 2018 at The St. Regis New York (Press release, Onconova, AUG 28, 2018, View Source [SID1234529094]). Steven M. Fruchtman, M.D., President and Chief Medical Officer of Onconova, Ramesh Kumar, CEO and Mark Guerin, CFO will attend the conference and be available to meet with investors.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation details
Date/Time: Wednesday, September 5th at 3:00p ET
Venue: The St. Regis New York, 2nd Floor: Fontainebleau Room
Presenter: Steven M. Fruchtman, M.D.